FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-222 | 70004-222-30 | Fentanyl Citrate | .05 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-222 | 70004-222-09 | Fentanyl Citrate | .05 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-229 | 70004-229-32 | Fentanyl Citrate | .01 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-229 | 70004-229-40 | Fentanyl Citrate | .01 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-244 | 70004-244-40 | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; .625 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-231 | 70004-231-64 | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-231 | 70004-231-32 | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-253 | 70004-253-40 | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-251 | 70004-251-64 | Fentanyl Citrate; Bupivacaine Hydrochloride | .005 mg/1 mL; .75 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-289 | 70004-289-64 | Fentanyl Citrate; Bupivacaine Hydrochloride | .005 mg/1 mL; 4 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-254 | 70004-254-40 | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-264 | 70004-264-22 | Fentanyl Citrate; Ropivacaine Hydrochloride | .002 mg/1 mL; 1 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-260 | 70004-260-32 | Fentanyl Citrate; Ropivacaine Hydrochloride | .002 mg/1 mL; 2 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-638 | 70004-638-09 | Glycopyrrolate | .2 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-300 | 70004-300-55 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-300 | 70004-300-18 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-300 | 70004-300-62 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-303 | 70004-303-17 | Hydromorphone Hydrochloride | 1 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-303 | 70004-303-21 | Hydromorphone Hydrochloride | 1 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-303 | 70004-303-16 | Hydromorphone Hydrochloride | 1 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-300 | 70004-300-30 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-300 | 70004-300-22 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-300 | 70004-300-16 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-302 | 70004-302-22 | Hydromorphone Hydrochloride | .5 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-430 | 70004-430-12 | Ketamine Hydrochloride | 10 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-430 | 70004-430-09 | Ketamine Hydrochloride | 10 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-433 | 70004-433-05 | Ketamine Hydrochloride | 50 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-700 | 70004-700-28 | Labetalol Hydrochloride | 5 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-720 | 70004-720-12 | Lidocaine Hydrochloride | 10 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-723 | 70004-723-09 | Lidocaine Hydrochloride | 20 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "Sincerus Florida, LLC(080105003)" | 72934-1411 | 72934-1411-2 | Cimetidine; Lidocaine; Salicylic Acid | 10 g/100 mL; 5 g/100 mL; 40 g/100 mL | 2021-2 | valid | 2026-11-12 | ||
| "STASKA PHARMACEUTICALS, INC.(099939403)" | 80098-010 | 80098-010-01 | Methylcobalamin | 25 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "STASKA PHARMACEUTICALS, INC.(099939403)" | 80098-017 | 80098-017-01 | Glutathione | 200 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "STASKA PHARMACEUTICALS, INC.(099939403)" | 80098-005 | 80098-005-01 | Lidocaine | 10 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "STASKA PHARMACEUTICALS, INC.(099939403)" | 80098-016 | 80098-016-01 | Lidocaine | 20 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "STASKA PHARMACEUTICALS, INC.(099939403)" | 80098-007 | 80098-007-03 | Ascorbic Acid | 500 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "STASKA PHARMACEUTICALS, INC.(099939403)" | 80098-007 | 80098-007-02 | Ascorbic Acid | 500 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "STASKA PHARMACEUTICALS, INC.(099939403)" | 80098-008 | 80098-008-01 | Lidocaine; Epinephrine | 10 mg/1 mL; .01 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "US Compounding, Inc.(607517146)" | Magnesium Hydroxide; Aluminum Hydroxide; Dimethicone; Lidocaine Hydrochloride | 17 g/1 mL; 17 g/1 mL; 1.7 g/1 mL; 5.7 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "US Compounding, Inc.(607517146)" | 62295-8235 | 62295-8235-1 | Promethazine | 25 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "US Compounding, Inc.(607517146)" | 62295-3323 | 62295-3323-7 | Succinylcholine Chloride | 20 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "US Compounding, Inc.(607517146)" | 62295-8236 | 62295-8236-3 | Tetracaine Hydrochloride; Racepinephrine Hydrochloride; Lidocaine Hydrochloride | 5 mg/1 mL; .5 mg/1 mL; 40 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "US Compounding, Inc.(607517146)" | 62295-3060 | 62295-3060-5 | Diphenhydramine Hydrochloride; Magnesium Hydroxide; Aluminum Hydroxide; Dimethicone; Lidocaine Hydrochloride | .8 mg/1 mL; 13.4 mg/1 mL; 13.4 mg/1 mL; 1.34 mg/1 mL; 6.6 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| AnazaoHealth Corporation | 796692619 | Lidocaine; Tetracaine; Benzocaine | 1 g/1 g; 1 g/1 g; 1 g/1 g | 2021-2 | source_no_ndc | 2026-11-12 | |||
| AnazaoHealth Corporation | 796692619 | Lysine Hydrochloride | 100 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| AnazaoHealth Corporation | 796692619 | Lysine Hydrochloride; Arginine Hydrochloride | 25 mg/1 mL; 25 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| AnazaoHealth Corporation | 796692619 | Methionine; Inositol; Choline Chloride | 25 mg/1 mL; 50 mg/1 mL; 50 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| AnazaoHealth Corporation | 796692619 | Methylcobalamin | 10000 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| AnazaoHealth Corporation | 796692619 | Methylcobalamin | 5000 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | |||
| AnazaoHealth Corporation | 796692619 | Nandrolone Decanoate | 200 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 |